MAGRAB E. BRENDAN 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Feb 5, 2019
Insider Transaction Report
Form 4
MAGRAB E. BRENDAN
DirectorChairman of the Board
Transactions
- Award
Common Stock Options
2019-02-03+986,842→ 986,842 totalExercise: $0.08From: 2020-02-03Exp: 2029-02-03→ Common Stock (986,842 underlying)